Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic

This cross-sectional study compares trends in prescribing buprenorphine to all Medicaid beneficiaries before and after the start of the COVID-19 pandemic.

Detalles Bibliográficos
Autores principales: Dowd, William N., Mark, Tami L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948527/
https://www.ncbi.nlm.nih.gov/pubmed/35323952
http://dx.doi.org/10.1001/jamanetworkopen.2022.4058
_version_ 1784674675627917312
author Dowd, William N.
Mark, Tami L.
author_facet Dowd, William N.
Mark, Tami L.
author_sort Dowd, William N.
collection PubMed
description This cross-sectional study compares trends in prescribing buprenorphine to all Medicaid beneficiaries before and after the start of the COVID-19 pandemic.
format Online
Article
Text
id pubmed-8948527
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-89485272022-04-11 Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic Dowd, William N. Mark, Tami L. JAMA Netw Open Research Letter This cross-sectional study compares trends in prescribing buprenorphine to all Medicaid beneficiaries before and after the start of the COVID-19 pandemic. American Medical Association 2022-03-24 /pmc/articles/PMC8948527/ /pubmed/35323952 http://dx.doi.org/10.1001/jamanetworkopen.2022.4058 Text en Copyright 2022 Dowd WN et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Dowd, William N.
Mark, Tami L.
Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
title Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
title_full Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
title_fullStr Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
title_full_unstemmed Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
title_short Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
title_sort changes in buprenorphine prescribing to medicaid beneficiaries during the first year of the covid-19 pandemic
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948527/
https://www.ncbi.nlm.nih.gov/pubmed/35323952
http://dx.doi.org/10.1001/jamanetworkopen.2022.4058
work_keys_str_mv AT dowdwilliamn changesinbuprenorphineprescribingtomedicaidbeneficiariesduringthefirstyearofthecovid19pandemic
AT marktamil changesinbuprenorphineprescribingtomedicaidbeneficiariesduringthefirstyearofthecovid19pandemic

Ejemplares similares